Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
More News related to BSX
- TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent
- Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery
- Boston Scientific (BSX) Announces U.S. District Court of Marshall, TX Rejects 2 Medtronic Patents
- Boston Scientific (BSX) Announces Court Rejects Two Medtronic (MDT) Patents
- Court Rejects Two Medtronic Patents
More News related to Press Releases
- BioCryst Pharma (BCRX) Reports Results From BCX-4208 Phase IIa Trial in Subjects With Psoriasis
- Celgene (CELG) Granted FDA Fast Track Designation for Amrubicin
- GTC Biotherapeutics (GTCB) Granted Priority Review from the FDA
- EPIX Pharmaceuticals (EPIX) To Regain Full Worldwide Commercial Rights For Vasovist(R)
NATICK, Mass., June 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2008 on Tuesday, July 22, at 8:30 a.m. ET.
The call will be hosted by Jim Tobin, President and Chief Executive Officer, and Sam Leno, Executive Vice President and Chief Financial Officer.
The live webcast and archived replay of this call will be available at www.bostonscientific.com in the Investor Relations section. The webcast is also being distributed over Thomson Financial's Investor Distribution Network via two locations: www.earnings.com, which is accessible to the public, and www.streetevents.com, a password-protected event management site.
To ensure a timely connection to the live webcast it is recommended that users register at least 15 minutes before the webcast begins. A replay of the webcast will begin at approximately 11:00 a.m. ET on July 22 and will be available for one year.
A press release will be issued after the close of the market on Monday, July 21.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
CONTACT: Paul Donovan
508-650-8541
Media Relations
Boston Scientific Corporation
Larry Neumann
508-650-8696
Investor Relations
Boston Scientific Corporation
SOURCE Boston Scientific Corporation
Related Categories
Press ReleasesStocks Mentioned
-0.46Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
